.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Fish and Richardson
Merck
Citi
Boehringer Ingelheim
Healthtrust
QuintilesIMS
Covington
Baxter

Generated: January 24, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: memantine hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-782-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-782-09)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-782-0330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-782-03)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-782-50500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-782-50)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-783-50500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-783-50)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-783-0330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-783-03)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-783-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-783-09)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-784-50500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-784-50)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-784-0330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-784-03)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-784-0990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-784-09)
Amneal PharmsMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205825ANDAAmneal Pharmaceuticals LLC65162-785-0330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-785-03)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
McKesson
US Army
Chinese Patent Office
Julphar
Moodys
Boehringer Ingelheim
Farmers Insurance
Novartis
US Department of Justice

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot